Novo Nordisk cuts the price of OzemPic to half to 499 dollars to pay the money, the qualified American patients

Photo of author

By [email protected]



Novo Nordsk He has Declared a comprehensive decrease At the cost Diabetes diabetes scentReducing the monthly price for American patients who pay money with type 2 diabetes from its previous list, which is about $ 1,000 to only 499 dollars. Follow the news Call calls to The greatest ability to bear the costs of drugs It may indicate a pivotal shift in the scene of pharmaceutical pricing.

Price reduction details

The logical basis behind nove

Novo Nordisk said the decision is part of a continuous effort to make the authenticity drugs approved by the FDA (FDA) can be more accessible, especially for those who may resort to unsafe alternatives. The company emphasized that the ability to afford costs is not only in response to the pressure of the competitive market – including Eli Lily’s continuous expansion in diabetes and obesity treatments – but also a direct effort to determine the priorities of patients’ safety and access to it.

“Improving access to our remedies adopted from the FDA is essential to our mission in Novo Nordisk,” Dave Moore saidExecutive Vice President, American Operations for Noversk. “Although OzemPIC is well covered with the United States, let us forget that there are some patients who are pushing outside this biological medicine. We believe that if one patient feels even the need to resort to uncomfortable and unconfredited KNOCKOFs alternatives, this is a lot.”

After the announcement, the Novo Nordisk shares jumped approximately 5 % while goods rose nearly 40 %. Analysts see the reduction of prices as a proactive response to the release of competing drugs and the continuous political scrutiny over the high prices of drugs in the United States.

In order to be clear, most insured diabetics in the United States are already paying much less than the price of the OzemPic full menu – usually less than $ 25 per month. However, the new program is particularly targeted with unbelievable or unbelievable persons who have faced more costs outside the pocket. The price reduction also comes shortly after Wegovy gets the approval of the Food and Drug Administration (FDA) to treat new liver borders, expand its indicators and connect the market.

For this story, luck The artificial intelligence is used to help with a preliminary draft. Check an editor of the accuracy of the information before publishing.

Submit 2025 Fortune Global 500The final ranking of the largest companies in the world. Explore this year’s list.



https://fortune.com/img-assets/wp-content/uploads/2025/08/GettyImages-2204555664-e1755534272656.jpg?resize=1200,600

Source link

Leave a Comment